Status: Recruiting
Clearance of Intracranial Blood Products by Continuous Irrigation With the IRRAflow System
The study is a multi-center prospective cohort, controlled, phase 4 post-market registry evaluating the efficacy and radiographic outcomes associated with the use of the IRRAflow® Active Fluid Exchange System compared to standard of care external ventricular drains.
Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Christopher P KellnerUpdated: Oct 28, 2025Locations: 1Duration: 6 Months
Eligibility criteria
Age >=18 years of age [+4]
GCS ≤ 5 [+3]